Showing results (711-720 of 737) with videos related to

Sort By:
Pageof 74
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 9, 1996
Immunochemiluminometric assay with two monoclonal antibodies against the N-terminal sequence of human parathyroid hormoneP Gao, H Schmidt-Gayk, K Dittrich, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2000
The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study GroupR A Rodby, R D Rohde, W R Clarke, et al.
European Journal of Medical Research|December 21, 2000
Interaction of the G protein beta 3 subunit T825 allele and the IRS-1 Arg972 variant in type 2 diabetesD Rosskopf, U Frey, S Eckhardt, et al.
Kidney International|August 1, 1997
Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritidesZ I Niemir, H Stein, G Dworacki, et al.
Biochimica Et Biophysica Acta|February 28, 2012
Toxic and non-toxic aggregates from the SBMA and normal forms of androgen receptor have distinct oligomeric structuresTobias Jochum, Manuela E Ritz, Christoph Schuster, et al.
Nephron|January 1, 1994
Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trialP Herrmann, E Ritz, H Schmidt-Gayk, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Pharmacokinetics of ramipril in hypertensive patients with renal insufficiencyH Schunkert, J Kindler, M Gassmann, et al.
Nature Genetics|January 13, 1998
Association of a human G-protein beta3 subunit variant with hypertensionW Siffert, D Rosskopf, G Siffert, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitusM Zumbach, M Hofmann, V Borcea, et al.
The New England Journal of Medicine|September 22, 2001
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesE J Lewis, L G Hunsicker, W R Clarke, et al.
Pageof 74